Blog
RSS FeedPosted by Michael Wonder on 16 Dec 2020
Health Canada approves Zolgensma, the one-time gene therapy for paediatric patients with spinal muscular atrophy
16 December 2020 - Zolgensma is designed to address the genetic root cause of SMA by replacing the missing or defective ...
Posted by Michael Wonder on 16 Dec 2020
Health Canada approves Venclexta (venetoclax) in combination with azacitidine or low dose cytarabine for untreated acute myeloid leukaemia
15 December 2020 - Health Canada's approval of Venclexta for newly diagnosed AML patients who are ineligible for intensive chemotherapy is ...
Posted by Michael Wonder on 10 Dec 2020
Ontario to begin vaccinations next week in Toronto, Ottawa
10 December 2020 - The first vaccines will go to health care workers at long-term care homes and other high-risk ...
Posted by Michael Wonder on 10 Dec 2020
Valeo Pharma announces Health Canada approval for Redesca and Redesca Hp
9 December 2020 - Valeo Pharma announced today that Health Canada has issued a Notice of Compliance for Redesca and ...
Posted by Michael Wonder on 09 Dec 2020
Canada health regulator approves Pfizer's COVID-19 vaccine
10 December 2020 - Canada’s health regulator has approved Pfizer’s COVID-19 vaccine. ...
Posted by Michael Wonder on 09 Dec 2020
First coronavirus vaccine shots could be doled out in Canada next week
7 December 2020 - A select few Canadians could receive the country’s first coronavirus vaccine shots as early as next ...
Posted by Michael Wonder on 06 Dec 2020
How COVID-19 vaccines are being approved in Canada
5 December 2020 - Measures have been taken to expedite the approval process. ...
Posted by Michael Wonder on 03 Dec 2020
Janssen seeks Health Canada approval for its COVID-19 vaccine
1 December 2020 - Regulator currently evaluating data from 4 vaccine makers. ...
Posted by Michael Wonder on 02 Dec 2020
Health Canada licenses Xeomin (incobotulinumtoxinA) for adult patients with sialorrhea
1 December 2020 - Merz Therapeutics today announced Health Canada’s notice of compliance for Xeomin (incobotulinumtoxinA) for the treatment of chronic ...
Posted by Michael Wonder on 26 Nov 2020
Lynparza (olaparib) receives Health Canada approval for the treatment of BRCA or ATM gene-mutated metastatic castration-resistant prostate cancer
25 November 2020 - On 21 August 2020, Health Canada approved Lynparza (olaparib), for the treatment of adult patients with deleterious ...
Posted by Michael Wonder on 24 Nov 2020
Lilly and the Government of Canada sign an agreement for the supply of bamlanivimab to treat COVID-19 in Canada
24 November 2020 - Bamlanivimab is a SARS-CoV-2-neutralising antibody that emerged from the collaboration between Lilly and Vancouver-based AbCellera. ...
Posted by Michael Wonder on 24 Nov 2020
Rigel and Medison announce Health Canada approval of Tavalisse, an oral medication for the treatment of adults with chronic immune thrombocytopenia
23 November 2020 - Rigel Pharmaceuticals and Medison Pharma today announced that Health Canada has approved the new drug submission ...
Posted by Michael Wonder on 20 Nov 2020
Lilly's neutralising antibody bamlanivimab (LY-CoV555) receives interim authorisation from Health Canada as a treatment for COVID-19
20 November 2020 - Bamlanivimab emerged from collaboration between Lilly and Vancouver-based AbCellera. ...
Posted by Michael Wonder on 18 Nov 2020
Knight Therapeutics announces filing of supplement to a new drug submission for Nerlynx (neratinib) to treat HER2-positive metastatic breast cancer
3 September 2020 - Knight Therapeutics Inc. announced filing of the supplement to a new drug submission (SNDS) of Nerlynx ...
Posted by Michael Wonder on 18 Nov 2020
HLS Therapeutics announces Health Canada approval of Perseris for the treatment of schizophrenia
17 November 2020 - First once-monthly risperidone long-acting injectable used in the treatment of schizophrenia. ...